Healthcare -
Biotechnology - NASDAQ - US
$ 0.4001
-3.73 %
$ 3.34 M
Market Cap
-0.02
P/E
REVB - STOCK-BASED COMPENSATION
Stock-based Compensation REVB - Revelation Biosciences, Inc.
156 K
LAST VALUE
-42.49%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR